Neutrophil percentages in bronchoalveolar lavage fluid: Implications for diagnosing bacterial pneumonia in patients with immunocompromise and neutropenia
Authors:
- Kevin M. GrudzinskiKGKevin M. Grudzinski
- Samuel FenskeSFSamuel Fenske
- Alec PeltekianAPAlec Peltekian
- Nikolay S. MarkovNMNikolay S. Markov
- Anna PawlowskiAPAnna Pawlowski
- Mengjia KangMKMengjia Kang
- James M. WalterJWJames M. Walter
- Chiagozie I. PickensCPChiagozie I. Pickens
- Nandita R. NadigNNNandita R. Nadig
- Ankit AgrawalAAAnkit Agrawal
- Benjamin D. SingerBSBenjamin D. Singer
- Richard G. WunderinkRWRichard G. Wunderink
Preprint
Abstract
Background Pneumonia is the leading cause of infectious deaths and the most common infection identified in ICU patients. Assessment of bronchoalveolar lavage fluid (BALF) cellularity can aid in pneumonia diagnosis. Low percentages (Methods We analyzed a large cohort of BALF specimens obtained for routine care for suspected pneumonia in mechanically ventilated patients and enrolled in the single-center Successful Clinical Response In Pneumonia Therapy (SCRIPT) study. BALF neutrophils were reported as a percentage of leukocytes by the clinical laboratory. The etiology of each episode of suspected pneumonia was adjudicated by a committee of critical care physicians using a predefined protocol. Immunocompromise was defined using predetermined criteria by the study research team. Neutropenia was defined here as a peripheral ANC Results 688 mechanically ventilated patients with suspected pneumonia were included. 409 (59.4%) were male; median age was 62 [51,71]. 461 patients (67.0%) were immunocompetent, 149 (21.7%) were immunocompromised without neutropenia and 78 (11.3%) were neutropenic at some point during their admission. A total of 1746 BALs were performed. Fifty-seven BALs were obtained on a day where the patient’s ANCConclusion Among patients with bacterial pneumonia, BALF neutrophil percentage was not significantly decreased by a spectrum of immunocompromise. However, the subset of patients who were acutely neutropenic at the time of BAL sampling had significantly lower BALF % neutrophils. A traditional approach using BALF<50% to suggest against bacterial pneumonia may be inaccurate in this particular population.Keywords
This publication has 20 references indexed in Scilit:
- Novel and Rapid Diagnostics for Common Infections in the Critically Ill PatientInfectious Disease Clinics of North America, 2024
- An Adjudication Protocol for Severe PneumoniaOpen Forum Infectious Diseases, 2023
- Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015The Lancet Infectious Diseases, 2017
- Pneumonia in the neutropenic cancer patientCurrent Opinion in Pulmonary Medicine, 2015
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011
- International Study of the Prevalence and Outcomes of Infection in Intensive Care UnitsJAMA, 2009
- Neutrophil Recruitment to the Lungs during Bacterial PneumoniaInfection and Immunity, 2009
- Infection in Solid-Organ Transplant RecipientsNew England Journal of Medicine, 2007
- Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltratesCritical Care Medicine, 2000